Results 21 to 30 of about 28,874 (286)
Case Law: A Review of Selected Pharmaceutical Patents in the UK Courts during 2021
British Journal of Pharmacy, 2022 Patents lie at the interface between technology and law. This review provides a summary of four high-profile cases from 2021 in which patents in the pharmaceutical or medical space were litigated in the UK Courts.
Sarah-Jane Crawford +2 more
doaj +1 more source
Peptide‐based ligand antagonists block a Vibrio cholerae adhesin
FEBS Letters, EarlyView.The structure of a peptide‐binding domain of the Vibrio cholerae adhesin FrhA was solved by X‐ray crystallography, revealing how the inhibitory peptide AGYTD binds tightly at its Ca2+‐coordinated pocket. Structure‐guided design incorporating D‐amino acids enhanced binding affinity, providing a foundation for developing anti‐adhesion therapeutics ...
Mingyu Wang +9 more
wiley +1 more source
POLICY STUDY IN INDONESIA’S PATENT LEGAL SYSTEM
Law Reform: Jurnal Pembaharuan Hukum, 2019 The Indonesian Patent Law, which was first drafted in 1989, is quite a controversial. As a legal instrument, the Patent Law strongly reflects the monopolistic character. In fact, it raises strong resistance from the community.
V. Henry Soelistyo Budi
doaj +1 more source
Istiglâlu Barâati al-Ikhtirâ’ fî al-Qânûn al-Indûnîsî Dirâsah Fiqhiyah Taqwîmiyah
Al-Ihkam: Jurnal Hukum dan Pranata Sosial, 2020 Patent has a prominent place in people’s nowadays lives as it becomes the main mover of their advancement as well as a barometer of a nation’s development and treasure.
Husnul Haq, Arif Ali Arif
doaj +1 more source
Indian pharmaceutical patent prosecution: The changing role of Section 3(d). [PDF]
PLoS ONE, 2018 India, like many developing countries, only recently began to grant pharmaceutical product patents. Indian patent law includes a provision, Section 3(d), which tries to limit grant of "secondary" pharmaceutical patents, i.e.
Bhaven N Sampat, Kenneth C Shadlen
doaj +1 more source
Pharmaceutical Law and Patent Law
Journal of Clinical Trials and Regulations, 2021 The patent law and pharma laws and regulations need to be coordinated. The interpretative proposal of the author is that a patent claim aiming at protecting the invention as a medicinal product must necessarily be expressed using the appropriate terms provided for by the laws and regulations concerning the industrial medicinal product, such as ...
Carlo A. Piria, Carlo A. Piria
openaire +1 more source
Time after time – circadian clocks through the lens of oscillator theory
FEBS Letters, EarlyView.Oscillator theory bridges physics and circadian biology. Damped oscillators require external drivers, while limit cycles emerge from delayed feedback and nonlinearities. Coupling enables tissue‐level coherence, and entrainment aligns internal clocks with environmental cues.
Marta del Olmo +2 more
wiley +1 more source
Protection Measures for Unregistered Licensees under Patent Assignment Claims
Journal of Intellectual PropertyThe Korean Patent Act provides a legal mechanism for rightful owners to claim the transfer of patent rights filed by individuals lacking legitimate entitlement.
Kyoung Ho Kim
doaj +1 more source
Recent legal developments from a nanotechnology perspective
Nanotechnology Reviews, 2012 With the recent major changes to the patent law system, it is more important than ever for nanotechnology-based companies to reevaluate their patent strategy.
Thiessen Rose, Lozan Vladimir
doaj +1 more source
Molecular Oncology, EarlyView.Plasma‐based detection of actionable mutations is a promising approach in lung cancer management. Analysis of ctDNA with a multigene NGS panel identified TP53, KRAS, and EGFR as the most frequently altered, with TP53 and KRAS in treatment‐naïve patients and TP53 and EGFR in previously treated patients.
Giovanna Maria Stanfoca Casagrande +11 more
wiley +1 more source